Xtx Topco LTD Agenus Inc Transaction History

Xtx Topco LTD

$710 Million
Q1 2024

A detailed history of Xtx Topco LTD transactions in Agenus Inc stock. As of the latest transaction made, Xtx Topco LTD holds 74,399 shares of AGEN stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

74,399

Previous 77,203 3.63%

Holding current value

$1.24 Million

Previous $64,000 32.81%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.53 - $0.93 $1,486 - $2,607	-2,804 Reduced 3.63%	74,399 $43,000
Q4 2023 Feb 13, 2024	SELL	$0.63 - $1.14 $97,743 - $176,869	-155,149 Reduced 66.77%	77,203 $64,000
Q3 2023 Nov 13, 2023	BUY	$1.12 - $1.88 $193,431 - $324,689	172,707 Added 289.56%	232,352 $262,000
Q2 2023 Aug 14, 2023	SELL	$1.31 - $2.04 $133,906 - $208,526	-102,219 Reduced 63.15%	59,645 $95,000
Q1 2023 May 12, 2023	BUY	$1.45 - $2.95 $90,256 - $183,625	62,246 Added 62.48%	161,864 $246,000

Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $201,228 - $323,758	99,618 New	99,618 $239,000
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.64 $21,216 - $43,084	16,320 Added 53.24%	46,972 $91,000
Q1 2022 May 13, 2022	SELL	$2.35 - $3.47 $90,937 - $134,278	-38,697 Reduced 55.8%	30,652 $75,000
Q4 2021 Feb 11, 2022	BUY	$2.92 - $5.74 $202,499 - $398,063	69,349 New	69,349 $223,000
Q3 2021 Nov 12, 2021	SELL	$4.98 - $6.63 $427,941 - $569,729	-85,932 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.56 - $5.49 $100,858 - $216,295	39,398 Added 84.66%	85,932 $472,000
Q1 2021 May 14, 2021	BUY	$2.69 - $5.25 $125,176 - $244,303	46,534 New	46,534 $127,000

Others Institutions Holding AGEN

# of Institutions

128

Shares Held

205M

Call Options Held

1.18M

Put Options Held

69.8K

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account